Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 2
2011 2
2012 3
2013 1
2014 7
2015 9
2016 13
2017 15
2018 8
2019 10
2020 4
2021 4
2022 7
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

87 results

Results by year

Filters applied: . Clear all
Page 1
Clinical implementation of preemptive pharmacogenomics in psychiatry.
Skokou M, Karamperis K, Koufaki MI, Tsermpini EE, Pandi MT, Siamoglou S, Ferentinos P, Bartsakoulia M, Katsila T, Mitropoulou C, Patrinos GP; Consortium of the PREPARE study in Greece. Skokou M, et al. Among authors: katsila t. EBioMedicine. 2024 Mar;101:105009. doi: 10.1016/j.ebiom.2024.105009. Epub 2024 Feb 16. EBioMedicine. 2024. PMID: 38364700 Free PMC article.
A quest for the stereo-electronic requirements for selective agonism for the neurotrophin receptors TrkA and TrkB in 17-spirocyclic-dehydroepiandrosterone derivatives.
Narducci D, Charou D, Rogdakis T, Zota I, Bafiti V, Zervou M, Katsila T, Gravanis A, Prousis KC, Charalampopoulos I, Calogeropoulou T. Narducci D, et al. Among authors: katsila t. Front Mol Neurosci. 2023 Sep 28;16:1244133. doi: 10.3389/fnmol.2023.1244133. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37840771 Free PMC article.
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study.
Swen JJ, van der Wouden CH, Manson LE, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung KC, Deneer VH, Dupui M, Ingelman-Sundberg M, Jonsson S, Joefield-Roka C, Just KS, Karlsson MO, Konta L, Koopmann R, Kriek M, Lehr T, Mitropoulou C, Rial-Sebbag E, Rollinson V, Roncato R, Samwald M, Schaeffeler E, Skokou M, Schwab M, Steinberger D, Stingl JC, Tremmel R, Turner RM, van Rhenen MH, Dávila Fajardo CL, Dolžan V, Patrinos GP, Pirmohamed M, Sunder-Plassmann G, Toffoli G, Guchelaar HJ; Ubiquitous Pharmacogenomics Consortium. Swen JJ, et al. Lancet. 2023 Feb 4;401(10374):347-356. doi: 10.1016/S0140-6736(22)01841-4. Lancet. 2023. PMID: 36739136 Clinical Trial.
Untargeted Metabolomics for Disease-Specific Signatures.
Chalikiopoulou C, Gómez-Tamayo JC, Katsila T. Chalikiopoulou C, et al. Among authors: katsila t. Methods Mol Biol. 2023;2571:71-81. doi: 10.1007/978-1-0716-2699-3_7. Methods Mol Biol. 2023. PMID: 36152151
87 results